Keymed Biosciences, Inc. (2162) Cash flow

1 Followers

Keymed Biosciences, Inc. Cash Flow

HK:2162's free cash flow for Q4 2025 was ¥-552.97M. For the 2025 fiscal year, HK:2162's free cash flow was decreased by ¥-44.76M and operating cash flow was ¥-368.93M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	¥ -712.41M	¥ -789.63M	¥ -303.62M	¥ -401.93M	¥ -214.64M
Investing Cash Flow	¥ 39.08M	¥ 67.71M	¥ 468.20M	¥ -645.59M	¥ -2.04B
Financing Cash Flow	¥ 788.72M	¥ 283.90M	¥ 72.13M	¥ -8.06M	¥ 3.64B
End Cash Position	¥ 503.35M	¥ 418.41M	¥ 851.03M	¥ 604.07M	¥ 1.52B
Free Cash Flow	¥ -1.05B	¥ -1.00B	¥ -686.23M	¥ -681.48M	¥ -387.50M

Currency in CNY